|
CSNK2A1P expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.046400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.475600E-01 |
| Normal-vs-Stage2 |
6.868400E-01 |
| Normal-vs-Stage3 |
1.757160E-01 |
| Normal-vs-Stage4 |
8.568000E-01 |
| Stage1-vs-Stage2 |
4.889800E-01 |
| Stage1-vs-Stage3 |
5.187800E-02 |
| Stage1-vs-Stage4 |
9.249600E-01 |
| Stage2-vs-Stage3 |
4.273400E-01 |
| Stage2-vs-Stage4 |
6.896800E-01 |
| Stage3-vs-Stage4 |
3.605000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.569400E-01 |
| Normal-vs-AfricanAmerican |
7.068600E-01 |
| Normal-vs-Asian |
7.146200E-01 |
| Caucasian-vs-AfricanAmerican |
5.424400E-01 |
| Caucasian-vs-Asian |
6.608400E-01 |
| AfricanAmerican-vs-Asian |
7.926800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.934400E-01 |
| Normal-vs-Female |
1.056440E-02 |
| Male-vs-Female |
1.763120E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.313800E-01 |
| Normal-vs-Extreme_Weight |
5.759700E-02 |
| Normal-vs-Obese |
1.981640E-01 |
| Normal-vs-Extreme_Obese |
6.026200E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.111800E-01 |
| Normal_Weight-vs-Obese |
2.902000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.146600E-01 |
| Extreme_Weight-vs-Obese |
1.119860E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.746400E-01 |
| Obese-vs-Extreme_Obese |
2.785000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.058040E-01 |
| Normal-vs-Age(41-60Yrs) |
2.618200E-01 |
| Normal-vs-Age(61-80Yrs) |
3.642600E-01 |
| Normal-vs-Age(81-100Yrs) |
5.198400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.999160E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.254000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.570030E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.045800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.536470E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.547800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.034600E-01 |
| Normal-VS-Type2 PRCC |
8.666200E-01 |
| Normal-VS-KIRP CIMP |
3.814000E-02 |
| Normal-VS-Unclassified PRCC |
4.733600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.609800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.819300E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
9.523400E-03 |
| Type2 PRCC-VS-KIRP CIMP |
3.036000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.442300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.845600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.346200E-01 |
| Normal-vs-N1 |
5.953700E-02 |
| Normal-vs-N2 |
9.505600E-01 |
| N0-vs-N1 |
4.948200E-02 |
| N0-vs-N2 |
7.764400E-01 |
| N1-vs-N2 |
4.791000E-01 |
|
|
